| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Poultry Diseases | 3 | 2019 | 588 | 1.10 | Why? |
| Pasteurella multocida | 2 | 2019 | 4 | 0.98 | Why? |
| Pasteurella Infections | 2 | 2019 | 11 | 0.97 | Why? |
| Ducks | 2 | 2019 | 120 | 0.91 | Why? |
| Lipocalin-2 | 4 | 2019 | 156 | 0.86 | Why? |
| Flurbiprofen | 1 | 2018 | 3 | 0.78 | Why? |
| Iron, Dietary | 1 | 2018 | 13 | 0.76 | Why? |
| Cotinine | 1 | 2018 | 22 | 0.75 | Why? |
| Metabolism, Inborn Errors | 1 | 2018 | 51 | 0.73 | Why? |
| Celecoxib | 1 | 2018 | 49 | 0.73 | Why? |
| Escherichia coli Infections | 2 | 2019 | 348 | 0.71 | Why? |
| Leukemia, Monocytic, Acute | 1 | 2017 | 8 | 0.71 | Why? |
| Apoptosis | 4 | 2019 | 2335 | 0.70 | Why? |
| Azacitidine | 1 | 2017 | 42 | 0.69 | Why? |
| Voriconazole | 1 | 2019 | 206 | 0.69 | Why? |
| Protective Agents | 2 | 2017 | 250 | 0.69 | Why? |
| Nephritis | 1 | 2017 | 39 | 0.68 | Why? |
| Peroxidase | 1 | 2018 | 207 | 0.68 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 92 | 0.68 | Why? |
| Receptors, CCR2 | 1 | 2017 | 103 | 0.68 | Why? |
| Lactones | 1 | 2017 | 62 | 0.67 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.67 | Why? |
| Fluoroquinolones | 1 | 2018 | 235 | 0.65 | Why? |
| Cell Cycle | 2 | 2017 | 329 | 0.65 | Why? |
| Iron | 4 | 2019 | 619 | 0.64 | Why? |
| Tobacco Smoke Pollution | 1 | 2018 | 181 | 0.60 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.57 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.56 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.55 | Why? |
| Homeostasis | 2 | 2019 | 582 | 0.54 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.54 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.53 | Why? |
| Cell Line, Tumor | 6 | 2018 | 3608 | 0.52 | Why? |
| Anti-Bacterial Agents | 7 | 2019 | 10083 | 0.52 | Why? |
| Fluorescent Dyes | 1 | 2017 | 536 | 0.50 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2018 | 363 | 0.50 | Why? |
| Iron Overload | 3 | 2019 | 113 | 0.48 | Why? |
| Imidazoles | 1 | 2017 | 631 | 0.45 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.45 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.41 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.41 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.39 | Why? |
| Enterobactin | 2 | 2019 | 3 | 0.38 | Why? |
| Siderophores | 2 | 2019 | 12 | 0.38 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.37 | Why? |
| Dietary Fiber | 2 | 2019 | 73 | 0.37 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.37 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.36 | Why? |
| Cell Proliferation | 5 | 2019 | 1973 | 0.35 | Why? |
| Hyperalgesia | 2 | 2018 | 61 | 0.34 | Why? |
| Rural Population | 2 | 2018 | 2408 | 0.32 | Why? |
| Escherichia coli | 5 | 2019 | 1547 | 0.30 | Why? |
| Drug Resistance, Bacterial | 3 | 2019 | 1414 | 0.29 | Why? |
| Animals | 30 | 2021 | 78931 | 0.29 | Why? |
| Enterovirus A, Human | 2 | 2017 | 180 | 0.28 | Why? |
| Colitis | 2 | 2019 | 266 | 0.28 | Why? |
| Enzyme Activation | 4 | 2018 | 425 | 0.27 | Why? |
| Mice, Inbred C57BL | 7 | 2019 | 5542 | 0.27 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.26 | Why? |
| Reactive Oxygen Species | 3 | 2019 | 1136 | 0.26 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.25 | Why? |
| Interferon Type I | 3 | 2021 | 2789 | 0.25 | Why? |
| Fendiline | 1 | 2020 | 12 | 0.23 | Why? |
| Monensin | 1 | 2020 | 19 | 0.23 | Why? |
| Salicylanilides | 1 | 2020 | 35 | 0.23 | Why? |
| Fermentation | 2 | 2019 | 156 | 0.22 | Why? |
| Sertraline | 1 | 2020 | 29 | 0.22 | Why? |
| Microbial Sensitivity Tests | 3 | 2019 | 2886 | 0.22 | Why? |
| Half-Life | 2 | 2019 | 298 | 0.22 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.22 | Why? |
| Sertoli Cells | 1 | 2020 | 66 | 0.21 | Why? |
| Smad8 Protein | 1 | 2019 | 1 | 0.21 | Why? |
| Smad5 Protein | 1 | 2019 | 4 | 0.21 | Why? |
| Smad1 Protein | 1 | 2019 | 5 | 0.21 | Why? |
| Liver Cirrhosis, Experimental | 1 | 2019 | 7 | 0.21 | Why? |
| Inflammation | 3 | 2017 | 13255 | 0.21 | Why? |
| Phosphorylation | 3 | 2021 | 1060 | 0.21 | Why? |
| Thiamphenicol | 1 | 2019 | 1 | 0.20 | Why? |
| Ureteral Obstruction | 2 | 2017 | 61 | 0.20 | Why? |
| Autophagy | 2 | 2017 | 960 | 0.20 | Why? |
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 6 | 0.20 | Why? |
| Chromosomes, Bacterial | 1 | 2019 | 18 | 0.20 | Why? |
| Muscle Development | 1 | 2019 | 27 | 0.20 | Why? |
| Rats, Sprague-Dawley | 3 | 2018 | 987 | 0.20 | Why? |
| Vancomycin Resistance | 1 | 2019 | 55 | 0.20 | Why? |
| PTEN Phosphohydrolase | 1 | 2019 | 70 | 0.20 | Why? |
| Toxicity Tests, Acute | 1 | 2018 | 22 | 0.19 | Why? |
| Analgesia, Patient-Controlled | 1 | 2018 | 20 | 0.19 | Why? |
| Lipopeptides | 1 | 2021 | 229 | 0.19 | Why? |
| Tibial Neuropathy | 1 | 2018 | 5 | 0.19 | Why? |
| Spinal Nerve Roots | 1 | 2018 | 8 | 0.19 | Why? |
| Osteosarcoma | 1 | 2019 | 83 | 0.19 | Why? |
| Meninges | 1 | 2018 | 40 | 0.18 | Why? |
| Cell Survival | 3 | 2021 | 1581 | 0.18 | Why? |
| Porcine Reproductive and Respiratory Syndrome | 1 | 2018 | 47 | 0.18 | Why? |
| Goats | 1 | 2019 | 217 | 0.18 | Why? |
| Cyclin E | 1 | 2017 | 8 | 0.18 | Why? |
| Cyclin B1 | 1 | 2017 | 7 | 0.18 | Why? |
| Spinal Cord | 2 | 2017 | 281 | 0.18 | Why? |
| CDC2 Protein Kinase | 1 | 2017 | 6 | 0.18 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2019 | 104 | 0.18 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.18 | Why? |
| Morphine | 1 | 2018 | 71 | 0.18 | Why? |
| Cyclin D1 | 1 | 2017 | 22 | 0.18 | Why? |
| Radioactive Tracers | 1 | 2017 | 9 | 0.18 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2021 | 379 | 0.18 | Why? |
| Pain Measurement | 2 | 2018 | 533 | 0.18 | Why? |
| Aniline Compounds | 1 | 2018 | 120 | 0.18 | Why? |
| Radar | 1 | 2017 | 33 | 0.18 | Why? |
| Lactococcus lactis | 1 | 2017 | 45 | 0.18 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2019 | 159 | 0.18 | Why? |
| Receptor, PAR-2 | 1 | 2017 | 27 | 0.18 | Why? |
| Mitosis | 1 | 2017 | 43 | 0.18 | Why? |
| Escherichia coli Proteins | 1 | 2019 | 168 | 0.18 | Why? |
| Neuronavigation | 1 | 2017 | 12 | 0.18 | Why? |
| GTPase-Activating Proteins | 1 | 2017 | 36 | 0.17 | Why? |
| Fluorine Radioisotopes | 1 | 2017 | 59 | 0.17 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.17 | Why? |
| Spermatozoa | 1 | 2020 | 244 | 0.17 | Why? |
| Amygdala | 1 | 2017 | 42 | 0.17 | Why? |
| Staining and Labeling | 1 | 2018 | 169 | 0.17 | Why? |
| Cholestasis | 1 | 2018 | 114 | 0.17 | Why? |
| Epilepsy, Temporal Lobe | 1 | 2017 | 37 | 0.17 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 49 | 0.17 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 76 | 0.17 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 502 | 0.17 | Why? |
| Amino Sugars | 1 | 2016 | 27 | 0.17 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 71 | 0.17 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.17 | Why? |
| Electrocoagulation | 1 | 2017 | 72 | 0.16 | Why? |
| Protein Kinases | 1 | 2017 | 93 | 0.16 | Why? |
| Fibrosis | 2 | 2017 | 800 | 0.16 | Why? |
| Golgi Apparatus | 1 | 2017 | 178 | 0.16 | Why? |
| Colistin | 1 | 2019 | 217 | 0.16 | Why? |
| Vancomycin | 1 | 2019 | 328 | 0.16 | Why? |
| Neuroglia | 1 | 2016 | 130 | 0.16 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.15 | Why? |
| Hepatocytes | 1 | 2019 | 549 | 0.15 | Why? |
| Mice | 12 | 2019 | 21357 | 0.15 | Why? |
| Pyroptosis | 1 | 2017 | 168 | 0.15 | Why? |
| Bone Neoplasms | 1 | 2019 | 287 | 0.15 | Why? |
| Kidney Tubules | 1 | 2017 | 205 | 0.15 | Why? |
| Infertility, Male | 1 | 2020 | 322 | 0.15 | Why? |
| Neuralgia | 1 | 2016 | 99 | 0.15 | Why? |
| Gastrointestinal Microbiome | 2 | 2019 | 1961 | 0.15 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.15 | Why? |
| Rats | 3 | 2018 | 2764 | 0.14 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.14 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.14 | Why? |
| Testis | 1 | 2020 | 566 | 0.14 | Why? |
| Mouth Diseases | 1 | 2018 | 193 | 0.14 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.14 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.14 | Why? |
| Cell Differentiation | 2 | 2019 | 1338 | 0.14 | Why? |
| Gram-Negative Bacteria | 1 | 2019 | 473 | 0.14 | Why? |
| Myelodysplastic Syndromes | 1 | 2017 | 261 | 0.13 | Why? |
| Virus Attachment | 1 | 2021 | 1259 | 0.13 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.13 | Why? |
| Child Development | 1 | 2018 | 352 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.13 | Why? |
| Neurodevelopmental Disorders | 1 | 2018 | 284 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.13 | Why? |
| Oral Health | 1 | 2018 | 401 | 0.13 | Why? |
| Signal Transduction | 3 | 2020 | 7207 | 0.13 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.13 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.12 | Why? |
| Chickens | 1 | 2018 | 1010 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1014 | 0.12 | Why? |
| Virion | 1 | 2021 | 1444 | 0.12 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.12 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.12 | Why? |
| Spinal Cord Injuries | 1 | 2016 | 270 | 0.12 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.12 | Why? |
| Colon | 1 | 2017 | 669 | 0.11 | Why? |
| Positron-Emission Tomography | 1 | 2017 | 802 | 0.11 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.11 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.11 | Why? |
| Neutrophils | 2 | 2018 | 5476 | 0.11 | Why? |
| Intestines | 1 | 2017 | 817 | 0.11 | Why? |
| Disease Models, Animal | 6 | 2019 | 10998 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.11 | Why? |
| Mouth Neoplasms | 1 | 2017 | 463 | 0.11 | Why? |
| Male | 22 | 2021 | 367725 | 0.11 | Why? |
| Interferon-beta | 3 | 2021 | 979 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2019 | 1314 | 0.10 | Why? |
| Immune Evasion | 1 | 2020 | 2081 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.10 | Why? |
| Drug Design | 1 | 2021 | 2627 | 0.10 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.10 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.09 | Why? |
| Polysaccharides | 1 | 2016 | 854 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Extracellular Traps | 1 | 2017 | 1036 | 0.09 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.08 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.08 | Why? |
| T-Box Domain Proteins | 1 | 2006 | 62 | 0.08 | Why? |
| Genes, MHC Class I | 1 | 2006 | 81 | 0.08 | Why? |
| Promoter Regions, Genetic | 2 | 2021 | 823 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2006 | 64 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Female | 17 | 2021 | 380317 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2019 | 2105 | 0.08 | Why? |
| Transforming Growth Factor beta1 | 2 | 2017 | 204 | 0.08 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.07 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.07 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.07 | Why? |
| Cells, Cultured | 3 | 2021 | 5835 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.06 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Histocompatibility Antigens Class I | 1 | 2006 | 624 | 0.06 | Why? |
| China | 5 | 2021 | 50654 | 0.06 | Why? |
| Receptors, Serotonin, 5-HT3 | 1 | 2020 | 7 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.05 | Why? |
| Sendai virus | 1 | 2021 | 111 | 0.05 | Why? |
| Phagocytosis | 2 | 2017 | 409 | 0.05 | Why? |
| Mutagenesis, Site-Directed | 1 | 2021 | 449 | 0.05 | Why? |
| Epidermal Growth Factor | 1 | 2019 | 44 | 0.05 | Why? |
| Cell Fusion | 1 | 2021 | 400 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Geese | 1 | 2019 | 29 | 0.05 | Why? |
| Receptors, Nicotinic | 1 | 2020 | 81 | 0.05 | Why? |
| Adipogenesis | 1 | 2019 | 38 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Virus Replication | 2 | 2020 | 14331 | 0.05 | Why? |
| Enterococcus | 1 | 2019 | 73 | 0.05 | Why? |
| Nitric Oxide | 1 | 2006 | 769 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2019 | 134 | 0.05 | Why? |
| Muscle Proteins | 1 | 2019 | 64 | 0.05 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 245 | 0.05 | Why? |
| Intestinal Mucosa | 2 | 2017 | 1046 | 0.05 | Why? |
| Inulin | 1 | 2018 | 51 | 0.05 | Why? |
| Periodontal Index | 1 | 2018 | 16 | 0.05 | Why? |
| Hepcidins | 1 | 2019 | 97 | 0.05 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.05 | Why? |
| Gene Deletion | 1 | 2021 | 430 | 0.05 | Why? |
| Hydrolysis | 1 | 2018 | 160 | 0.05 | Why? |
| Lumbosacral Region | 1 | 2018 | 30 | 0.05 | Why? |
| DEAD Box Protein 58 | 1 | 2021 | 250 | 0.05 | Why? |
| RAW 264.7 Cells | 1 | 2019 | 316 | 0.05 | Why? |
| Swine | 2 | 2018 | 3352 | 0.05 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.05 | Why? |
| Protein Kinase C | 1 | 2018 | 58 | 0.05 | Why? |
| Cell Nucleus | 1 | 2021 | 399 | 0.05 | Why? |
| Ectopic Gene Expression | 1 | 2017 | 7 | 0.04 | Why? |
| Pain Threshold | 1 | 2018 | 46 | 0.04 | Why? |
| Phosphopyruvate Hydratase | 1 | 2018 | 47 | 0.04 | Why? |
| Luminescent Proteins | 1 | 2018 | 142 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Phosphate-Binding Proteins | 1 | 2017 | 34 | 0.04 | Why? |
| Dextran Sulfate | 1 | 2017 | 54 | 0.04 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2017 | 23 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2019 | 400 | 0.04 | Why? |
| Porcine respiratory and reproductive syndrome virus | 1 | 2018 | 91 | 0.04 | Why? |
| ADP-Ribosylation Factor 1 | 1 | 2017 | 19 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Adipocytes | 1 | 2019 | 173 | 0.04 | Why? |
| Nucleic Acid Conformation | 1 | 2021 | 621 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| Chemotaxis | 1 | 2017 | 67 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Sulfones | 1 | 2017 | 66 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.04 | Why? |
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 49 | 0.04 | Why? |
| Sus scrofa | 1 | 2018 | 205 | 0.04 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.04 | Why? |
| Reverse Genetics | 1 | 2021 | 439 | 0.04 | Why? |
| Child Nutrition Disorders | 1 | 2018 | 86 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Receptors, Immunologic | 1 | 2021 | 555 | 0.04 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.04 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2018 | 203 | 0.04 | Why? |
| CD4-CD8 Ratio | 1 | 2017 | 235 | 0.04 | Why? |
| Protein Binding | 3 | 2017 | 11430 | 0.04 | Why? |
| CD3 Complex | 1 | 2017 | 237 | 0.04 | Why? |
| Helminths | 1 | 2016 | 60 | 0.04 | Why? |
| Interferon-gamma | 1 | 2006 | 2711 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Protein Transport | 1 | 2017 | 487 | 0.04 | Why? |
| Methanol | 1 | 2017 | 149 | 0.04 | Why? |
| Sirolimus | 1 | 2017 | 240 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.04 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2021 | 1638 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.04 | Why? |
| Up-Regulation | 2 | 2017 | 2249 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Macrophages | 1 | 2006 | 2784 | 0.03 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.03 | Why? |
| Maternal Health | 1 | 2018 | 331 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Th2 Cells | 1 | 2017 | 680 | 0.03 | Why? |
| Pyrrolidines | 1 | 2017 | 558 | 0.03 | Why? |
| HeLa Cells | 1 | 2017 | 1303 | 0.03 | Why? |
| Open Reading Frames | 1 | 2020 | 1898 | 0.03 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.03 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2018 | 954 | 0.03 | Why? |
| Base Sequence | 1 | 2021 | 3581 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Immunity, Innate | 2 | 2021 | 6570 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.03 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.03 | Why? |
| Gene Expression Regulation | 2 | 2019 | 4020 | 0.03 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.02 | Why? |
| Genetic Vectors | 2 | 2006 | 1600 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Leukemia L1210 | 1 | 2006 | 1 | 0.02 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.02 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.02 | Why? |
| NIH 3T3 Cells | 1 | 2006 | 147 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2006 | 274 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Gene Transfer Techniques | 1 | 2006 | 134 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Trans-Activators | 1 | 2006 | 170 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Nuclear Proteins | 1 | 2006 | 321 | 0.02 | Why? |
| Transfection | 1 | 2006 | 864 | 0.02 | Why? |
| Virus Diseases | 1 | 2021 | 3779 | 0.02 | Why? |
| Plasmids | 1 | 2006 | 840 | 0.02 | Why? |
| Genetic Therapy | 1 | 2006 | 409 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Structure-Activity Relationship | 1 | 2006 | 2219 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Recombination, Genetic | 1 | 2006 | 1265 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Survival Rate | 1 | 2006 | 9206 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |